Nitroglycerine
| NG | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 227.09 g/mol [1] |
| Appearance | VISCOUS LIQUID [1] |
| Taste | Sweet, burning taste [1] |
| Density | 1.6 (NIOSH, 2024) - Denser than water; will sink [1] |
| Melting point | 56 °F (NIOSH, 2024) [1] |
| Boiling point | Begins to decompose at 122-140 °F (NIOSH, 2024) [1] |
| Decomposition | Begins to decompose at 50-60 °C, appreciable volatile at 100 °C evolves nitrous yellow vapors at 135 °C. [1] |
| Solubility | 0.1 % (NIOSH, 2024) [1] |
| Predicted LogP | 1.6 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C3H5N3O9 |
| IUPAC name | 1,3-dinitrooxypropan-2-yl nitrate |
| SMILES | C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-] |
| InChI | InChI=1S/C3H5N3O9/c7-4(8)13-1-3(15-6(11)12)2-14-5(9)10/h3H,1-2H2 |
| InChIKey | SNIOPGDIGTZGOP-UHFFFAOYSA-N |
| CAS number | 55-63-0 |
| UNII | G59M7S0WS3 |
| PubChem CID | 4510 |
Nitroglycerine (also known as Glyceryl trinitrate, Trinitroglycerin, Nitrostat, Nitroglycerol, Glycerol trinitrate, Trinitroglycerol, Nitro-dur, Minitran, Trinitrin or Nitronet).
Chemistry
Stereochemistry []
Nitroglycerine is achiral.
Druglikeness
Lipinski's rule of five
Nitroglycerine matches Lipinski's rule of five.Pharmacology
ATC Classification
- cardiovascular system (C)
- cardiac therapy (C01)
- vasodilators used in cardiac diseases (C01D)
- organic nitrates (C01DA)
- (C01DA02)
- glyceryl trinitrate (C01DA02)
- vasoprotectives (C05)
- agents for treatment of hemorrhoids and anal fissures for topical use (C05A)
- muscle relaxants (C05AE)
- glyceryl trinitrate (C05AE01)
MeSH Classification
Mechanism of action []
Nitroglycerin is converted by mitochondrial aldehyde dehydrogenase in smooth muscle cells to nitric oxide (NO), a potent vasodilator. NO activates the enzyme guanylate cyclase, which converts guanosine triphosphate (GTP) to cyclic guanosine 3',5'-monophosphate (cGMP) in vascular smooth muscle and other tissues. cGMP is an endogenous vasodilator of vascular smooth muscle: it causes protein kinase-dependent phosphorylation and activates downstream cascades that promote relaxation and increased blood flow in veins, arteries and cardiac tissue. An _in vitro_ study using mouse aorta suggests that nitric oxide, an active metabolite of nitroglycerin, targets the natriuretic peptide receptors. [1]
Medical side effects []
103 side effects listed on drug labels in SIDER 4.1 (nitroglycerin).
- Headache
- Throbbing headache
- Nausea
- Vomiting
- Dizziness
- Syncope
- Hypotension
- Hypotensive
- Shock
- Collapse
- Loss of consciousness
- Dermatitis contact
- Allergic contact dermatitis
- Pruritus
- Application site erythema
- Angina pectoris
- Angina unstable
- Dermatitis atopic
- Hypersensitivity
- Flushing
- Orthostatic hypotension
- Tachycardia
- Reflex tachycardia
- Dermatitis exfoliative
- Abdominal pain
- Abdominal colic
- Gastrointestinal pain
- Anaphylactic shock
- Anaphylactoid reaction
- Angioedema
- Arrhythmia
- Asthenia
- Mental disorder
- Coma
- Infection
- Confusional state
- Feeling abnormal
- Cyanosis
- Drug eruption
- Fixed drug eruption
- Somnolence
- Dyspnoea
- Eczema
- Dermatitis
- Rash
- Body temperature increased
- Gastrointestinal disorder
- Breath odour
- Atrioventricular block
- Cardiac disorder
- Immune system disorder
- Ischaemia
- Renal failure acute
- Mediastinal disorder
- Methaemoglobinaemia
- Nervous system disorder
- Pallor
- Palpitations
- Paraesthesia
- Pharyngitis
- Rhinitis
- Stomatitis
- Hyperhidrosis
- Sweating increased
- Erythema
- Redness
- Urticaria
- Angiopathy
- Vascular headache
- Vasodilation procedure
- Vertigo
- Burning sensation
- Agitation
- Oedema peripheral
- Application site reaction
- Diarrhoea haemorrhagic
- Intracranial pressure increased
- Skin disorder
- Hyperventilation
- Tachypnoea
- Immobile
- Respiratory rate decreased
- Bradycardia
- Pulse rate decrease marked
- Clonic convulsion
- Drug tolerance
- Swollen tongue
- Vision blurred
- Rash generalised
- Withdrawal hypertension
- Application site irritation
- Paralysis
- Hypovolaemia
- Visual impairment
- Skin reaction
- Menopausal symptoms
- Hot flush
- Hypoxia
- Infestation
- Application site pruritus
- Chest discomfort
- Cerebral ischaemia
- Glucose-6-phosphate dehydrogenase deficiency
Indications
- Acute myocardial infarction
- Acute pulmonary oedema
- Anal fissure
- Angina pectoris
- Anginal attack
- Arteriospasm coronary
- Cardiac failure congestive
- Cardiac index
- Cerebrovascular accident
- Chronic anal fissure
- Coronary artery disease
- Coronary heart disease
- Discomfort
- Exercise induced angina
- Haemorrhoids
- Hypertension
- Hypotension
- Intraoperative hypotension
- Left ventricular failure
- Myocardial infarction
- Nephropathy
- Pain
- Prinzmetal angina
- Stable angina pectoris
- Tachycardia
- Tension
- Vascular resistance
- Vascular resistance systemic
- Vasodilation
- Ventricular extrasystoles
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 4510, Nitroglycerine. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/4510
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Nitroglycerine. UNII: G59M7S0WS3. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/G59M7S0WS3
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 20:00:41 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 20:00:37 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 20:00:37 |
| gsrs | ok | 2026-11-20 20:00:37 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0014865) | 2026-11-20 20:00:37 |
| kegg | ok | 2026-11-20 20:00:41 |
| pubchem | ok | 2026-11-20 20:00:36 |
| missing (no r/tripreports posts mention it) | 2026-11-20 20:00:37 | |
| sider | ok | 2026-11-20 20:00:37 |
| structure | ok | 2026-11-20 20:00:37 |
| wikipedia | missing (no Wikipedia article with a drug infobox) | 2026-11-20 20:00:37 |